Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US study says triglycerides do not predict CHD (coronary heart disease) risk:

This article was originally published in Clinica

Executive Summary

Measurement of serum triglycerides provides no additional predictive information in patients at risk from coronary heart disease (CHD) beyond that provided by measurement of serum cholesterol alone, a US study has confirmed. The relationship between serum triglycerides and CHD has remained enigmatic despite 40 years of research. The latest study, published in the July 10 issue of Archives of Internal Medicine, was based on a retrospective analysis of data from three large lipid studies and found that triglyceride measurements did not improve discrimination between subjects who did and did not go on to suffer a myocardial infarct.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT076654

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel